Notice of Effectiveness
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: February 7, 2022 4:00 P.M.
Form: S-3
CIK: 0001867096
Company Name: Xeris Biopharma Holdings, Inc.
File Number: 333-262404